These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18991241)

  • 21. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
    Friedel G; Budach W; Dippon J; Spengler W; Eschmann SM; Pfannenberg C; Al-Kamash F; Walles T; Aebert H; Kyriss T; Veit S; Kimmich M; Bamberg M; Kohlhaeufl M; Steger V; Hehr T
    J Clin Oncol; 2010 Feb; 28(6):942-8. PubMed ID: 20100967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II trial of preoperative concurrent radiation therapy and weekly paclitaxel/carboplatin for patients with locally advanced non-small-cell lung cancer.
    Hainsworth JD; Gray JR; Litchy S; Bearden JD; Shaffer DW; Houston GA; Greco FA
    Clin Lung Cancer; 2004 Jul; 6(1):33-42. PubMed ID: 15310415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of symptom-to-treatment interval on prognosis in lung cancer.
    Annakkaya AN; Arbak P; Balbay O; Bilgin C; Erbas M; Bulut I
    Tumori; 2007; 93(1):61-7. PubMed ID: 17455873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morbidity in video-assisted thoracoscopic lobectomy for clinical stage I non-small cell lung cancer: is VATS lobectomy really safe?
    Kawachi R; Tsukada H; Nakazato Y; Takei H; Koshi-ishi Y; Goya T
    Thorac Cardiovasc Surg; 2009 Apr; 57(3):156-9. PubMed ID: 19330753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment delays in non-small cell lung cancer and their prognostic implications.
    Diaconescu R; Lafond C; Whittom R
    J Thorac Oncol; 2011 Jul; 6(7):1254-9. PubMed ID: 21610526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
    Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
    Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is the extent of the advantage of video-assisted thoracoscopic surgical resection over thoracotomy in terms of delivery of adjuvant chemotherapy following non-small-cell lung cancer resection?
    Teh E; Abah U; Church D; Saka W; Talbot D; Belcher E; Black E
    Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):656-60. PubMed ID: 25015538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study.
    Cerfolio RJ; Bryant AS
    J Thorac Cardiovasc Surg; 2008 Feb; 135(2):261-8. PubMed ID: 18242247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does timeliness of care in Non-Small Cell Lung Cancer impact on survival?
    Vinod SK; Chandra A; Berthelsen A; Descallar J
    Lung Cancer; 2017 Oct; 112():16-24. PubMed ID: 29191589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delays in the diagnosis and surgical treatment of lung cancer.
    Billing JS; Wells FC
    Thorax; 1996 Sep; 51(9):903-6. PubMed ID: 8984700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of rapid investigation clinic on timeliness of lung cancer diagnosis and treatment.
    Ezer N; Navasakulpong A; Schwartzman K; Ofiara L; Gonzalez AV
    BMC Pulm Med; 2017 Dec; 17(1):178. PubMed ID: 29216855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of delays on survival in the surgical treatment of bronchogenic carcinoma.
    Aragoneses FG; Moreno N; Leon P; Fontan EG; Folque E;
    Lung Cancer; 2002 Apr; 36(1):59-63. PubMed ID: 11891034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
    Rice TW; Adelstein DJ; Koka A; Tefft M; Kirby TJ; Van Kirk MA; Taylor ME; Olencki TE; Peereboom D; Budd GT
    Ann Thorac Surg; 1995 Sep; 60(3):586-91; discussion 591-2. PubMed ID: 7677484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.
    Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH
    Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anatomic thoracoscopic lung resection for non-small cell lung cancer in stage I is associated with less morbidity and shorter hospitalization than thoracotomy.
    Ilonen IK; Räsänen JV; Knuuttila A; Salo JA; Sihvo EI
    Acta Oncol; 2011 Oct; 50(7):1126-32. PubMed ID: 21314296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative staging of lung cancer with combined PET-CT.
    Fischer B; Lassen U; Mortensen J; Larsen S; Loft A; Bertelsen A; Ravn J; Clementsen P; Høgholm A; Larsen K; Rasmussen T; Keiding S; Dirksen A; Gerke O; Skov B; Steffensen I; Hansen H; Vilmann P; Jacobsen G; Backer V; Maltbaek N; Pedersen J; Madsen H; Nielsen H; Højgaard L
    N Engl J Med; 2009 Jul; 361(1):32-9. PubMed ID: 19571281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfer between hospitals as a predictor of delay in diagnosis and treatment of patients with Non-Small Cell Lung Cancer - a register based cohort-study.
    Iachina M; Jakobsen E; Fallesen AK; Green A
    BMC Health Serv Res; 2017 Apr; 17(1):267. PubMed ID: 28403839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Delays in the diagnosis and treatment of lung cancer for patients treated with radiation therapy].
    Rivera C; Mathiaux J; Haaser T; Begueret H; Jougon J; Trouette R
    Bull Cancer; 2012 Dec; 99(12):1117-22. PubMed ID: 23015117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: a multi-center phase II study.
    Juan O; Sánchez-Hernández A; Vázquez S; Casal J; Firvida JL; Aparisi F; Muñoz J; García-Sánchez J; Gironés R; Lázaro M; Giner V
    Anticancer Res; 2014 Apr; 34(4):1959-66. PubMed ID: 24692732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.